TCR2 Therapeutics Inc. (TCRR)
NASDAQ: TCRR · IEX Real-Time Price · USD
2.94
+0.05 (1.73%)
At close: Jul 5, 2022 4:00 PM
3.00
+0.06 (2.04%)
After-hours:
Jul 5, 2022 6:46 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Selling, General & Admin
|
22.5 | 16.72 | 13.89 | 6.78 | 3.61 | 2.26 |
| Research & Development
|
77.24 | 51.98 | 37.49 | 19.67 | 9.57 | 7.67 |
| Other Operating Expenses
|
0 | 0 | 0 | 0 | 0 | -0.02 |
| Operating Expenses
|
99.74 | 68.7 | 51.38 | 26.45 | 13.18 | 9.92 |
| Operating Income
|
-99.74 | -68.7 | -51.38 | -26.45 | -13.18 | -9.92 |
| Other Expense / Income
|
-0.22 | -1.74 | -3.89 | -2.2 | -0.11 | 0 |
| Pretax Income
|
-99.52 | -66.96 | -47.5 | -24.25 | -13.07 | -9.92 |
| Income Tax
|
0.29 | 0.16 | 0.1 | 0 | 0 | 0 |
| Net Income
|
-99.81 | -67.12 | -47.6 | -24.25 | -13.07 | -9.92 |
| Preferred Dividends
|
0 | 0 | 49.9 | 37.3 | 1.79 | 0.79 |
| Net Income Common
|
-99.81 | -67.12 | -97.5 | -61.55 | -14.86 | -10.7 |
| Shares Outstanding (Basic)
|
38 | 28 | 21 | 1 | 0 | 0 |
| Shares Outstanding (Diluted)
|
38 | 28 | 21 | 1 | 0 | 0 |
| Shares Change
|
35.53% | 32.63% | 3278.52% | 67.87% | 34.35% | - |
| EPS (Basic)
|
-2.63 | -2.40 | -4.62 | -98.53 | -39.94 | -38.64 |
| EPS (Diluted)
|
-2.63 | -2.40 | -4.62 | -98.53 | -39.94 | -38.64 |
| Free Cash Flow Per Share
|
-2.45 | -2.28 | -2.14 | -31.63 | -33.33 | -37.00 |
| Effective Tax Rate
|
-0.29% | -0.24% | -0.21% | 0.00% | 0.00% | 0.00% |
| EBITDA
|
-96.69 | -65.37 | -46.64 | -23.83 | -12.77 | -9.7 |
| Depreciation & Amortization
|
2.83 | 1.59 | 0.86 | 0.42 | 0.3 | 0.22 |
| EBIT
|
-99.52 | -66.96 | -47.5 | -24.25 | -13.07 | -9.92 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).